nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—HTR2B—Sorafenib—thyroid cancer	0.2	0.307	CbGbCtD
Mianserin—HTR2C—Sorafenib—thyroid cancer	0.13	0.2	CbGbCtD
Mianserin—CYP2B6—Sorafenib—thyroid cancer	0.0806	0.124	CbGbCtD
Mianserin—CYP2B6—Doxorubicin—thyroid cancer	0.0489	0.0753	CbGbCtD
Mianserin—CYP1A2—Sorafenib—thyroid cancer	0.0473	0.0727	CbGbCtD
Mianserin—CYP3A4—Vandetanib—thyroid cancer	0.0411	0.0632	CbGbCtD
Mianserin—CYP2D6—Sorafenib—thyroid cancer	0.0389	0.0599	CbGbCtD
Mianserin—CYP3A4—Sorafenib—thyroid cancer	0.0248	0.0381	CbGbCtD
Mianserin—CYP2D6—Doxorubicin—thyroid cancer	0.0236	0.0364	CbGbCtD
Mianserin—CYP3A4—Doxorubicin—thyroid cancer	0.015	0.0231	CbGbCtD
Mianserin—Electrocardiogram QT prolonged—Vandetanib—thyroid cancer	0.00843	0.0397	CcSEcCtD
Mianserin—Torsade de pointes—Vandetanib—thyroid cancer	0.00772	0.0363	CcSEcCtD
Mianserin—Cardiac failure—Vandetanib—thyroid cancer	0.00403	0.019	CcSEcCtD
Mianserin—Lethargy—Vandetanib—thyroid cancer	0.00401	0.0189	CcSEcCtD
Mianserin—Cardiac arrest—Vandetanib—thyroid cancer	0.00374	0.0176	CcSEcCtD
Mianserin—Gynaecomastia—Sorafenib—thyroid cancer	0.00327	0.0154	CcSEcCtD
Mianserin—Neutropenia—Vandetanib—thyroid cancer	0.00317	0.015	CcSEcCtD
Mianserin—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00303	0.0143	CcSEcCtD
Mianserin—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00286	0.0135	CcSEcCtD
Mianserin—Bradycardia—Vandetanib—thyroid cancer	0.00277	0.013	CcSEcCtD
Mianserin—Cardiac failure—Sorafenib—thyroid cancer	0.00272	0.0128	CcSEcCtD
Mianserin—Eye disorder—Vandetanib—thyroid cancer	0.00254	0.012	CcSEcCtD
Mianserin—Cardiac disorder—Vandetanib—thyroid cancer	0.00252	0.0119	CcSEcCtD
Mianserin—Angiopathy—Vandetanib—thyroid cancer	0.00247	0.0116	CcSEcCtD
Mianserin—Mediastinal disorder—Vandetanib—thyroid cancer	0.00245	0.0115	CcSEcCtD
Mianserin—Breast disorder—Sorafenib—thyroid cancer	0.00239	0.0113	CcSEcCtD
Mianserin—Mental disorder—Vandetanib—thyroid cancer	0.00238	0.0112	CcSEcCtD
Mianserin—Tremor—Vandetanib—thyroid cancer	0.00222	0.0104	CcSEcCtD
Mianserin—Neutropenia—Sorafenib—thyroid cancer	0.00214	0.0101	CcSEcCtD
Mianserin—Erectile dysfunction—Sorafenib—thyroid cancer	0.00211	0.00993	CcSEcCtD
Mianserin—Loss of consciousness—Vandetanib—thyroid cancer	0.00208	0.00979	CcSEcCtD
Mianserin—Convulsion—Vandetanib—thyroid cancer	0.00205	0.00965	CcSEcCtD
Mianserin—Hypertension—Vandetanib—thyroid cancer	0.00204	0.00962	CcSEcCtD
Mianserin—Arthralgia—Vandetanib—thyroid cancer	0.00201	0.00948	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.002	0.00942	CcSEcCtD
Mianserin—Bone marrow depression—Epirubicin—thyroid cancer	0.002	0.00941	CcSEcCtD
Mianserin—Jaundice—Sorafenib—thyroid cancer	0.00199	0.00937	CcSEcCtD
Mianserin—Dry mouth—Vandetanib—thyroid cancer	0.00197	0.00928	CcSEcCtD
Mianserin—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00193	0.00909	CcSEcCtD
Mianserin—Oedema—Vandetanib—thyroid cancer	0.00193	0.00909	CcSEcCtD
Mianserin—Nervous system disorder—Vandetanib—thyroid cancer	0.00189	0.00892	CcSEcCtD
Mianserin—Thrombocytopenia—Vandetanib—thyroid cancer	0.00189	0.0089	CcSEcCtD
Mianserin—Skin disorder—Vandetanib—thyroid cancer	0.00188	0.00883	CcSEcCtD
Mianserin—Bone marrow depression—Doxorubicin—thyroid cancer	0.00185	0.00871	CcSEcCtD
Mianserin—Connective tissue disorder—Sorafenib—thyroid cancer	0.0018	0.00848	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00176	0.00828	CcSEcCtD
Mianserin—Paraesthesia—Vandetanib—thyroid cancer	0.00173	0.00816	CcSEcCtD
Mianserin—Tinnitus—Sorafenib—thyroid cancer	0.00171	0.00805	CcSEcCtD
Mianserin—Cardiac disorder—Sorafenib—thyroid cancer	0.0017	0.00801	CcSEcCtD
Mianserin—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00167	0.00785	CcSEcCtD
Mianserin—Fatigue—Vandetanib—thyroid cancer	0.00166	0.00784	CcSEcCtD
Mianserin—Angiopathy—Sorafenib—thyroid cancer	0.00166	0.00783	CcSEcCtD
Mianserin—Mediastinal disorder—Sorafenib—thyroid cancer	0.00165	0.00778	CcSEcCtD
Mianserin—Constipation—Vandetanib—thyroid cancer	0.00165	0.00778	CcSEcCtD
Mianserin—Blood disorder—Epirubicin—thyroid cancer	0.00162	0.00761	CcSEcCtD
Mianserin—Mental disorder—Sorafenib—thyroid cancer	0.00161	0.00756	CcSEcCtD
Mianserin—Blood disorder—Doxorubicin—thyroid cancer	0.00149	0.00704	CcSEcCtD
Mianserin—Anaemia—Sorafenib—thyroid cancer	0.00147	0.00695	CcSEcCtD
Mianserin—Syncope—Sorafenib—thyroid cancer	0.00143	0.00674	CcSEcCtD
Mianserin—Leukopenia—Sorafenib—thyroid cancer	0.00143	0.00673	CcSEcCtD
Mianserin—Loss of consciousness—Sorafenib—thyroid cancer	0.0014	0.00661	CcSEcCtD
Mianserin—Asthenia—Vandetanib—thyroid cancer	0.00139	0.00652	CcSEcCtD
Mianserin—Hypertension—Sorafenib—thyroid cancer	0.00138	0.00649	CcSEcCtD
Mianserin—Pruritus—Vandetanib—thyroid cancer	0.00137	0.00643	CcSEcCtD
Mianserin—Arthralgia—Sorafenib—thyroid cancer	0.00136	0.0064	CcSEcCtD
Mianserin—Myalgia—Sorafenib—thyroid cancer	0.00136	0.0064	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00135	0.00635	CcSEcCtD
Mianserin—Dry mouth—Sorafenib—thyroid cancer	0.00133	0.00626	CcSEcCtD
Mianserin—Shock—Sorafenib—thyroid cancer	0.00128	0.00603	CcSEcCtD
Mianserin—Nervous system disorder—Sorafenib—thyroid cancer	0.00128	0.00601	CcSEcCtD
Mianserin—Dizziness—Vandetanib—thyroid cancer	0.00128	0.00601	CcSEcCtD
Mianserin—Thrombocytopenia—Sorafenib—thyroid cancer	0.00128	0.00601	CcSEcCtD
Mianserin—Skin disorder—Sorafenib—thyroid cancer	0.00127	0.00596	CcSEcCtD
Mianserin—Rash—Vandetanib—thyroid cancer	0.00122	0.00573	CcSEcCtD
Mianserin—Dermatitis—Vandetanib—thyroid cancer	0.00122	0.00573	CcSEcCtD
Mianserin—Headache—Vandetanib—thyroid cancer	0.00121	0.0057	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00119	0.00559	CcSEcCtD
Mianserin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00112	0.0053	CcSEcCtD
Mianserin—Fatigue—Sorafenib—thyroid cancer	0.00112	0.00529	CcSEcCtD
Mianserin—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00112	0.00528	CcSEcCtD
Mianserin—Constipation—Sorafenib—thyroid cancer	0.00111	0.00524	CcSEcCtD
Mianserin—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00104	0.00488	CcSEcCtD
Mianserin—Cardiac failure—Epirubicin—thyroid cancer	0.001	0.00473	CcSEcCtD
Mianserin—Lethargy—Epirubicin—thyroid cancer	0.000999	0.00471	CcSEcCtD
Mianserin—Diplopia—Epirubicin—thyroid cancer	0.000979	0.00461	CcSEcCtD
Mianserin—HTR1F—head—thyroid cancer	0.000952	0.0732	CbGeAlD
Mianserin—Asthenia—Sorafenib—thyroid cancer	0.000934	0.0044	CcSEcCtD
Mianserin—Cardiac arrest—Epirubicin—thyroid cancer	0.000931	0.00439	CcSEcCtD
Mianserin—Cardiac failure—Doxorubicin—thyroid cancer	0.000928	0.00437	CcSEcCtD
Mianserin—Lethargy—Doxorubicin—thyroid cancer	0.000925	0.00435	CcSEcCtD
Mianserin—Pruritus—Sorafenib—thyroid cancer	0.000921	0.00434	CcSEcCtD
Mianserin—Diplopia—Doxorubicin—thyroid cancer	0.000906	0.00427	CcSEcCtD
Mianserin—Breast disorder—Epirubicin—thyroid cancer	0.000885	0.00417	CcSEcCtD
Mianserin—Cardiac arrest—Doxorubicin—thyroid cancer	0.000862	0.00406	CcSEcCtD
Mianserin—Dizziness—Sorafenib—thyroid cancer	0.000861	0.00406	CcSEcCtD
Mianserin—Rash—Sorafenib—thyroid cancer	0.000821	0.00387	CcSEcCtD
Mianserin—Dermatitis—Sorafenib—thyroid cancer	0.00082	0.00386	CcSEcCtD
Mianserin—Breast disorder—Doxorubicin—thyroid cancer	0.000819	0.00386	CcSEcCtD
Mianserin—Headache—Sorafenib—thyroid cancer	0.000816	0.00384	CcSEcCtD
Mianserin—Pancytopenia—Epirubicin—thyroid cancer	0.000804	0.00379	CcSEcCtD
Mianserin—Neutropenia—Epirubicin—thyroid cancer	0.000791	0.00373	CcSEcCtD
Mianserin—Weight increased—Epirubicin—thyroid cancer	0.00077	0.00363	CcSEcCtD
Mianserin—Drowsiness—Epirubicin—thyroid cancer	0.000755	0.00355	CcSEcCtD
Mianserin—Pancytopenia—Doxorubicin—thyroid cancer	0.000744	0.0035	CcSEcCtD
Mianserin—Jaundice—Epirubicin—thyroid cancer	0.000736	0.00346	CcSEcCtD
Mianserin—Neutropenia—Doxorubicin—thyroid cancer	0.000732	0.00345	CcSEcCtD
Mianserin—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000714	0.00336	CcSEcCtD
Mianserin—Weight increased—Doxorubicin—thyroid cancer	0.000713	0.00336	CcSEcCtD
Mianserin—HTR7—neck—thyroid cancer	0.000713	0.0548	CbGeAlD
Mianserin—Agranulocytosis—Epirubicin—thyroid cancer	0.000704	0.00332	CcSEcCtD
Mianserin—Drowsiness—Doxorubicin—thyroid cancer	0.000698	0.00329	CcSEcCtD
Mianserin—Bradycardia—Epirubicin—thyroid cancer	0.00069	0.00325	CcSEcCtD
Mianserin—Jaundice—Doxorubicin—thyroid cancer	0.000681	0.00321	CcSEcCtD
Mianserin—Hepatitis—Epirubicin—thyroid cancer	0.000677	0.00319	CcSEcCtD
Mianserin—DRD3—head—thyroid cancer	0.000673	0.0517	CbGeAlD
Mianserin—Connective tissue disorder—Epirubicin—thyroid cancer	0.000666	0.00314	CcSEcCtD
Mianserin—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00066	0.00311	CcSEcCtD
Mianserin—Agranulocytosis—Doxorubicin—thyroid cancer	0.000652	0.00307	CcSEcCtD
Mianserin—HTR6—head—thyroid cancer	0.000647	0.0498	CbGeAlD
Mianserin—Bradycardia—Doxorubicin—thyroid cancer	0.000638	0.00301	CcSEcCtD
Mianserin—Eye disorder—Epirubicin—thyroid cancer	0.000633	0.00298	CcSEcCtD
Mianserin—Tinnitus—Epirubicin—thyroid cancer	0.000632	0.00297	CcSEcCtD
Mianserin—Cardiac disorder—Epirubicin—thyroid cancer	0.000629	0.00296	CcSEcCtD
Mianserin—Hepatitis—Doxorubicin—thyroid cancer	0.000627	0.00295	CcSEcCtD
Mianserin—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000616	0.0029	CcSEcCtD
Mianserin—Angiopathy—Epirubicin—thyroid cancer	0.000615	0.00289	CcSEcCtD
Mianserin—Mediastinal disorder—Epirubicin—thyroid cancer	0.000611	0.00288	CcSEcCtD
Mianserin—OPRK1—head—thyroid cancer	0.000599	0.0461	CbGeAlD
Mianserin—Mental disorder—Epirubicin—thyroid cancer	0.000594	0.0028	CcSEcCtD
Mianserin—HRH2—head—thyroid cancer	0.000592	0.0455	CbGeAlD
Mianserin—Eye disorder—Doxorubicin—thyroid cancer	0.000586	0.00276	CcSEcCtD
Mianserin—Tinnitus—Doxorubicin—thyroid cancer	0.000584	0.00275	CcSEcCtD
Mianserin—Cardiac disorder—Doxorubicin—thyroid cancer	0.000582	0.00274	CcSEcCtD
Mianserin—Angiopathy—Doxorubicin—thyroid cancer	0.000569	0.00268	CcSEcCtD
Mianserin—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000565	0.00266	CcSEcCtD
Mianserin—Mental disorder—Doxorubicin—thyroid cancer	0.000549	0.00259	CcSEcCtD
Mianserin—Anaemia—Epirubicin—thyroid cancer	0.000545	0.00257	CcSEcCtD
Mianserin—Agitation—Epirubicin—thyroid cancer	0.000542	0.00255	CcSEcCtD
Mianserin—Vertigo—Epirubicin—thyroid cancer	0.00053	0.0025	CcSEcCtD
Mianserin—Syncope—Epirubicin—thyroid cancer	0.000529	0.00249	CcSEcCtD
Mianserin—Leukopenia—Epirubicin—thyroid cancer	0.000528	0.00249	CcSEcCtD
Mianserin—Loss of consciousness—Epirubicin—thyroid cancer	0.000518	0.00244	CcSEcCtD
Mianserin—Convulsion—Epirubicin—thyroid cancer	0.000511	0.00241	CcSEcCtD
Mianserin—Hypertension—Epirubicin—thyroid cancer	0.000509	0.0024	CcSEcCtD
Mianserin—Anaemia—Doxorubicin—thyroid cancer	0.000504	0.00238	CcSEcCtD
Mianserin—Myalgia—Epirubicin—thyroid cancer	0.000502	0.00236	CcSEcCtD
Mianserin—Arthralgia—Epirubicin—thyroid cancer	0.000502	0.00236	CcSEcCtD
Mianserin—Agitation—Doxorubicin—thyroid cancer	0.000501	0.00236	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000499	0.00235	CcSEcCtD
Mianserin—Dry mouth—Epirubicin—thyroid cancer	0.000491	0.00231	CcSEcCtD
Mianserin—Vertigo—Doxorubicin—thyroid cancer	0.00049	0.00231	CcSEcCtD
Mianserin—Syncope—Doxorubicin—thyroid cancer	0.000489	0.0023	CcSEcCtD
Mianserin—Leukopenia—Doxorubicin—thyroid cancer	0.000488	0.0023	CcSEcCtD
Mianserin—Confusional state—Epirubicin—thyroid cancer	0.000485	0.00229	CcSEcCtD
Mianserin—Oedema—Epirubicin—thyroid cancer	0.000481	0.00227	CcSEcCtD
Mianserin—Loss of consciousness—Doxorubicin—thyroid cancer	0.00048	0.00226	CcSEcCtD
Mianserin—Shock—Epirubicin—thyroid cancer	0.000474	0.00223	CcSEcCtD
Mianserin—Convulsion—Doxorubicin—thyroid cancer	0.000473	0.00223	CcSEcCtD
Mianserin—Nervous system disorder—Epirubicin—thyroid cancer	0.000472	0.00222	CcSEcCtD
Mianserin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000471	0.00222	CcSEcCtD
Mianserin—Hypertension—Doxorubicin—thyroid cancer	0.000471	0.00222	CcSEcCtD
Mianserin—Tachycardia—Epirubicin—thyroid cancer	0.00047	0.00221	CcSEcCtD
Mianserin—Skin disorder—Epirubicin—thyroid cancer	0.000468	0.0022	CcSEcCtD
Mianserin—Myalgia—Doxorubicin—thyroid cancer	0.000465	0.00219	CcSEcCtD
Mianserin—Arthralgia—Doxorubicin—thyroid cancer	0.000465	0.00219	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000461	0.00217	CcSEcCtD
Mianserin—Dry mouth—Doxorubicin—thyroid cancer	0.000454	0.00214	CcSEcCtD
Mianserin—Hypotension—Epirubicin—thyroid cancer	0.00045	0.00212	CcSEcCtD
Mianserin—Confusional state—Doxorubicin—thyroid cancer	0.000449	0.00211	CcSEcCtD
Mianserin—Oedema—Doxorubicin—thyroid cancer	0.000445	0.0021	CcSEcCtD
Mianserin—HTR2A—neck—thyroid cancer	0.000444	0.0342	CbGeAlD
Mianserin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000439	0.00207	CcSEcCtD
Mianserin—Shock—Doxorubicin—thyroid cancer	0.000438	0.00206	CcSEcCtD
Mianserin—Nervous system disorder—Doxorubicin—thyroid cancer	0.000437	0.00206	CcSEcCtD
Mianserin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000436	0.00205	CcSEcCtD
Mianserin—Tachycardia—Doxorubicin—thyroid cancer	0.000435	0.00205	CcSEcCtD
Mianserin—Skin disorder—Doxorubicin—thyroid cancer	0.000433	0.00204	CcSEcCtD
Mianserin—Paraesthesia—Epirubicin—thyroid cancer	0.000432	0.00204	CcSEcCtD
Mianserin—HTR7—trachea—thyroid cancer	0.000429	0.033	CbGeAlD
Mianserin—Somnolence—Epirubicin—thyroid cancer	0.000428	0.00202	CcSEcCtD
Mianserin—Hypotension—Doxorubicin—thyroid cancer	0.000416	0.00196	CcSEcCtD
Mianserin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000416	0.00196	CcSEcCtD
Mianserin—Fatigue—Epirubicin—thyroid cancer	0.000415	0.00195	CcSEcCtD
Mianserin—HRH2—lymph node—thyroid cancer	0.000414	0.0319	CbGeAlD
Mianserin—Constipation—Epirubicin—thyroid cancer	0.000412	0.00194	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000406	0.00191	CcSEcCtD
Mianserin—Paraesthesia—Doxorubicin—thyroid cancer	0.0004	0.00188	CcSEcCtD
Mianserin—Feeling abnormal—Epirubicin—thyroid cancer	0.000397	0.00187	CcSEcCtD
Mianserin—HTR2B—thyroid gland—thyroid cancer	0.000396	0.0304	CbGeAlD
Mianserin—Somnolence—Doxorubicin—thyroid cancer	0.000396	0.00186	CcSEcCtD
Mianserin—ADRA2C—trachea—thyroid cancer	0.000394	0.0303	CbGeAlD
Mianserin—SLC6A3—head—thyroid cancer	0.000387	0.0297	CbGeAlD
Mianserin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000384	0.00181	CcSEcCtD
Mianserin—Fatigue—Doxorubicin—thyroid cancer	0.000384	0.00181	CcSEcCtD
Mianserin—Constipation—Doxorubicin—thyroid cancer	0.000381	0.00179	CcSEcCtD
Mianserin—HTR1D—head—thyroid cancer	0.000378	0.029	CbGeAlD
Mianserin—HTR2C—head—thyroid cancer	0.000374	0.0288	CbGeAlD
Mianserin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000367	0.00173	CcSEcCtD
Mianserin—SLC6A4—head—thyroid cancer	0.000355	0.0273	CbGeAlD
Mianserin—HTR2B—head—thyroid cancer	0.000351	0.027	CbGeAlD
Mianserin—Asthenia—Epirubicin—thyroid cancer	0.000345	0.00163	CcSEcCtD
Mianserin—Pruritus—Epirubicin—thyroid cancer	0.000341	0.0016	CcSEcCtD
Mianserin—HRH1—trachea—thyroid cancer	0.00032	0.0246	CbGeAlD
Mianserin—Asthenia—Doxorubicin—thyroid cancer	0.00032	0.0015	CcSEcCtD
Mianserin—Dizziness—Epirubicin—thyroid cancer	0.000318	0.0015	CcSEcCtD
Mianserin—Pruritus—Doxorubicin—thyroid cancer	0.000315	0.00148	CcSEcCtD
Mianserin—HTR1A—head—thyroid cancer	0.000315	0.0242	CbGeAlD
Mianserin—ADRA2A—trachea—thyroid cancer	0.000314	0.0242	CbGeAlD
Mianserin—SLC6A2—head—thyroid cancer	0.000312	0.024	CbGeAlD
Mianserin—Rash—Epirubicin—thyroid cancer	0.000303	0.00143	CcSEcCtD
Mianserin—Dermatitis—Epirubicin—thyroid cancer	0.000303	0.00143	CcSEcCtD
Mianserin—Headache—Epirubicin—thyroid cancer	0.000302	0.00142	CcSEcCtD
Mianserin—HTR7—head—thyroid cancer	0.000301	0.0231	CbGeAlD
Mianserin—Dizziness—Doxorubicin—thyroid cancer	0.000295	0.00139	CcSEcCtD
Mianserin—DRD2—head—thyroid cancer	0.000285	0.0219	CbGeAlD
Mianserin—Rash—Doxorubicin—thyroid cancer	0.000281	0.00132	CcSEcCtD
Mianserin—Dermatitis—Doxorubicin—thyroid cancer	0.000281	0.00132	CcSEcCtD
Mianserin—Headache—Doxorubicin—thyroid cancer	0.000279	0.00131	CcSEcCtD
Mianserin—ADRA2C—head—thyroid cancer	0.000277	0.0213	CbGeAlD
Mianserin—CYP1A2—thyroid gland—thyroid cancer	0.000271	0.0208	CbGeAlD
Mianserin—HTR2A—trachea—thyroid cancer	0.000267	0.0206	CbGeAlD
Mianserin—ADRA2A—thyroid gland—thyroid cancer	0.000249	0.0191	CbGeAlD
Mianserin—HTR2B—lymph node—thyroid cancer	0.000246	0.0189	CbGeAlD
Mianserin—CYP2B6—head—thyroid cancer	0.00023	0.0177	CbGeAlD
Mianserin—HRH1—head—thyroid cancer	0.000225	0.0173	CbGeAlD
Mianserin—ADRA2A—head—thyroid cancer	0.000221	0.017	CbGeAlD
Mianserin—SLC6A2—lymph node—thyroid cancer	0.000219	0.0168	CbGeAlD
Mianserin—ADRA2C—lymph node—thyroid cancer	0.000194	0.0149	CbGeAlD
Mianserin—HTR2A—head—thyroid cancer	0.000188	0.0144	CbGeAlD
Mianserin—CYP2D6—head—thyroid cancer	0.000171	0.0131	CbGeAlD
Mianserin—HRH1—lymph node—thyroid cancer	0.000157	0.0121	CbGeAlD
Mianserin—ADRA2A—lymph node—thyroid cancer	0.000155	0.0119	CbGeAlD
Mianserin—ADRA2B—Signaling Pathways—TERT—thyroid cancer	2.52e-05	0.000202	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CCND1—thyroid cancer	2.48e-05	0.000198	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TERT—thyroid cancer	2.43e-05	0.000195	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TERT—thyroid cancer	2.42e-05	0.000194	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—KRAS—thyroid cancer	2.42e-05	0.000194	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—KRAS—thyroid cancer	2.41e-05	0.000193	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—HIF1A—thyroid cancer	2.41e-05	0.000193	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—PTEN—thyroid cancer	2.39e-05	0.000191	CbGpPWpGaD
Mianserin—ADRA2B—Hemostasis—AKT1—thyroid cancer	2.39e-05	0.000191	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—KRAS—thyroid cancer	2.38e-05	0.000191	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—KRAS—thyroid cancer	2.38e-05	0.000191	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NRG1—thyroid cancer	2.38e-05	0.00019	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—BRAF—thyroid cancer	2.37e-05	0.00019	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—KRAS—thyroid cancer	2.37e-05	0.00019	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—KRAS—thyroid cancer	2.36e-05	0.000189	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TERT—thyroid cancer	2.35e-05	0.000188	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—NRAS—thyroid cancer	2.35e-05	0.000188	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NRG1—thyroid cancer	2.34e-05	0.000187	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NRG1—thyroid cancer	2.33e-05	0.000187	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—AKT1—thyroid cancer	2.33e-05	0.000187	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	2.33e-05	0.000186	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—HIF1A—thyroid cancer	2.31e-05	0.000185	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.3e-05	0.000185	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PPARG—thyroid cancer	2.29e-05	0.000183	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—SLC5A5—thyroid cancer	2.28e-05	0.000183	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—HIF1A—thyroid cancer	2.25e-05	0.00018	CbGpPWpGaD
Mianserin—ADRA2C—Hemostasis—AKT1—thyroid cancer	2.23e-05	0.000179	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—BRAF—thyroid cancer	2.21e-05	0.000177	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—KRAS—thyroid cancer	2.18e-05	0.000175	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—KRAS—thyroid cancer	2.17e-05	0.000174	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—TP53—thyroid cancer	2.15e-05	0.000172	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TERT—thyroid cancer	2.14e-05	0.000171	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—NRAS—thyroid cancer	2.13e-05	0.000171	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	2.13e-05	0.00017	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—NRAS—thyroid cancer	2.12e-05	0.00017	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—TP53—thyroid cancer	2.1e-05	0.000168	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TERT—thyroid cancer	2.1e-05	0.000168	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TERT—thyroid cancer	2.1e-05	0.000168	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—HRAS—thyroid cancer	2.05e-05	0.000165	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—HRAS—thyroid cancer	2.05e-05	0.000164	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	2.05e-05	0.000164	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HIF1A—thyroid cancer	2.04e-05	0.000164	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	2.04e-05	0.000163	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—HRAS—thyroid cancer	2.02e-05	0.000162	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—KRAS—thyroid cancer	2.02e-05	0.000162	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—HRAS—thyroid cancer	2.02e-05	0.000162	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—HRAS—thyroid cancer	2.01e-05	0.000161	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—HRAS—thyroid cancer	2.01e-05	0.000161	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—HIF1A—thyroid cancer	2.01e-05	0.000161	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HIF1A—thyroid cancer	2e-05	0.000161	CbGpPWpGaD
Mianserin—OPRK1—GPCR downstream signaling—AKT1—thyroid cancer	2e-05	0.00016	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—BRAF—thyroid cancer	1.99e-05	0.00016	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—TPR—thyroid cancer	1.99e-05	0.00016	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—NRAS—thyroid cancer	1.98e-05	0.000159	CbGpPWpGaD
Mianserin—HTR6—GPCR downstream signaling—AKT1—thyroid cancer	1.97e-05	0.000158	CbGpPWpGaD
Mianserin—HTR7—GPCR downstream signaling—AKT1—thyroid cancer	1.97e-05	0.000158	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.96e-05	0.000157	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—AKT1—thyroid cancer	1.95e-05	0.000156	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—TP53—thyroid cancer	1.94e-05	0.000155	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.93e-05	0.000155	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CCND1—thyroid cancer	1.93e-05	0.000154	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—BRAF—thyroid cancer	1.93e-05	0.000154	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—RXRA—thyroid cancer	1.92e-05	0.000154	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—BRAF—thyroid cancer	1.92e-05	0.000153	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TERT—thyroid cancer	1.91e-05	0.000153	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CCND1—thyroid cancer	1.9e-05	0.000152	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CCND1—thyroid cancer	1.9e-05	0.000152	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CCND1—thyroid cancer	1.88e-05	0.000151	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—BRAF—thyroid cancer	1.86e-05	0.000149	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—PTEN—thyroid cancer	1.86e-05	0.000149	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PPARG—thyroid cancer	1.86e-05	0.000149	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—HRAS—thyroid cancer	1.86e-05	0.000149	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—HRAS—thyroid cancer	1.85e-05	0.000148	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—KRAS—thyroid cancer	1.83e-05	0.000147	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—PTEN—thyroid cancer	1.83e-05	0.000147	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—PTEN—thyroid cancer	1.83e-05	0.000147	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	1.83e-05	0.000146	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	1.83e-05	0.000146	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—PTEN—thyroid cancer	1.82e-05	0.000146	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—AKT1—thyroid cancer	1.81e-05	0.000145	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—AKT1—thyroid cancer	1.81e-05	0.000145	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.81e-05	0.000145	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PTGS2—thyroid cancer	1.8e-05	0.000144	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—NRAS—thyroid cancer	1.8e-05	0.000144	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—AKT1—thyroid cancer	1.8e-05	0.000144	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—AKT1—thyroid cancer	1.79e-05	0.000143	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—AKT1—thyroid cancer	1.79e-05	0.000143	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—AKT1—thyroid cancer	1.78e-05	0.000142	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—AKT1—thyroid cancer	1.77e-05	0.000142	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	1.77e-05	0.000142	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—NRAS—thyroid cancer	1.77e-05	0.000141	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	1.76e-05	0.000141	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	1.75e-05	0.00014	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PPARG—thyroid cancer	1.74e-05	0.00014	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CCND1—thyroid cancer	1.73e-05	0.000139	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—HRAS—thyroid cancer	1.72e-05	0.000138	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—KRAS—thyroid cancer	1.71e-05	0.000137	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—BRAF—thyroid cancer	1.69e-05	0.000135	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—PTEN—thyroid cancer	1.67e-05	0.000134	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—AKT1—thyroid cancer	1.67e-05	0.000134	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—BRAF—thyroid cancer	1.66e-05	0.000133	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—BRAF—thyroid cancer	1.66e-05	0.000133	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—NRAS—thyroid cancer	1.66e-05	0.000133	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—AKT1—thyroid cancer	1.64e-05	0.000131	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—NRAS—thyroid cancer	1.63e-05	0.000131	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—NRAS—thyroid cancer	1.63e-05	0.000131	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—AKT1—thyroid cancer	1.63e-05	0.000131	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TP53—thyroid cancer	1.63e-05	0.000131	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—RXRA—thyroid cancer	1.62e-05	0.00013	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—NRAS—thyroid cancer	1.62e-05	0.00013	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CCND1—thyroid cancer	1.61e-05	0.000129	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	1.61e-05	0.000129	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.58e-05	0.000127	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PTEN—thyroid cancer	1.57e-05	0.000126	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—HRAS—thyroid cancer	1.56e-05	0.000125	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—PTEN—thyroid cancer	1.56e-05	0.000125	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	1.55e-05	0.000124	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—KRAS—thyroid cancer	1.55e-05	0.000124	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	1.52e-05	0.000122	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—KRAS—thyroid cancer	1.52e-05	0.000122	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—AKT1—thyroid cancer	1.52e-05	0.000122	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	1.51e-05	0.000121	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	1.51e-05	0.000121	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	1.5e-05	0.00012	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.49e-05	0.00012	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—NRAS—thyroid cancer	1.49e-05	0.00012	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	1.49e-05	0.000119	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PTGS2—thyroid cancer	1.46e-05	0.000117	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.46e-05	0.000117	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	1.46e-05	0.000117	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—HRAS—thyroid cancer	1.45e-05	0.000116	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	1.45e-05	0.000116	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—KRAS—thyroid cancer	1.43e-05	0.000114	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—AKT1—thyroid cancer	1.41e-05	0.000113	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—KRAS—thyroid cancer	1.41e-05	0.000113	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—KRAS—thyroid cancer	1.41e-05	0.000113	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CCND1—thyroid cancer	1.41e-05	0.000113	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	1.41e-05	0.000113	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CCND1—thyroid cancer	1.4e-05	0.000112	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—KRAS—thyroid cancer	1.4e-05	0.000112	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NRAS—thyroid cancer	1.39e-05	0.000111	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	1.39e-05	0.000111	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—AKT1—thyroid cancer	1.38e-05	0.00011	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	1.37e-05	0.00011	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PTGS2—thyroid cancer	1.37e-05	0.00011	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CCND1—thyroid cancer	1.36e-05	0.000109	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—PTEN—thyroid cancer	1.36e-05	0.000109	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—PTEN—thyroid cancer	1.35e-05	0.000108	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	1.32e-05	0.000106	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	1.32e-05	0.000105	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—HRAS—thyroid cancer	1.32e-05	0.000105	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PTEN—thyroid cancer	1.31e-05	0.000105	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	1.29e-05	0.000104	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—HRAS—thyroid cancer	1.29e-05	0.000103	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—KRAS—thyroid cancer	1.28e-05	0.000103	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—AKT1—thyroid cancer	1.28e-05	0.000103	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	1.28e-05	0.000102	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PTEN—thyroid cancer	1.28e-05	0.000102	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TP53—thyroid cancer	1.27e-05	0.000102	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	1.26e-05	0.000101	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	1.26e-05	0.000101	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—RXRA—thyroid cancer	1.25e-05	0.0001	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	1.25e-05	0.0001	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TP53—thyroid cancer	1.25e-05	0.0001	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TP53—thyroid cancer	1.25e-05	0.0001	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TP53—thyroid cancer	1.24e-05	9.94e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCND1—thyroid cancer	1.23e-05	9.88e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCND1—thyroid cancer	1.21e-05	9.72e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—HRAS—thyroid cancer	1.21e-05	9.72e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCND1—thyroid cancer	1.21e-05	9.7e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PPARG—thyroid cancer	1.21e-05	9.7e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NRAS—thyroid cancer	1.21e-05	9.69e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NRAS—thyroid cancer	1.2e-05	9.64e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—HRAS—thyroid cancer	1.2e-05	9.58e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PTEN—thyroid cancer	1.2e-05	9.57e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—KRAS—thyroid cancer	1.2e-05	9.57e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—HRAS—thyroid cancer	1.19e-05	9.57e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PTEN—thyroid cancer	1.19e-05	9.54e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—HRAS—thyroid cancer	1.19e-05	9.51e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	1.18e-05	9.43e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PTEN—thyroid cancer	1.17e-05	9.39e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NRAS—thyroid cancer	1.17e-05	9.38e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PTEN—thyroid cancer	1.17e-05	9.37e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—AKT1—thyroid cancer	1.16e-05	9.31e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	1.15e-05	9.17e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	1.14e-05	9.16e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TP53—thyroid cancer	1.14e-05	9.14e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—AKT1—thyroid cancer	1.14e-05	9.14e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	1.1e-05	8.85e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—HRAS—thyroid cancer	1.09e-05	8.74e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	1.08e-05	8.64e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—AKT1—thyroid cancer	1.07e-05	8.58e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	1.07e-05	8.54e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NRAS—thyroid cancer	1.06e-05	8.51e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TP53—thyroid cancer	1.06e-05	8.51e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—AKT1—thyroid cancer	1.06e-05	8.46e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—AKT1—thyroid cancer	1.05e-05	8.45e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—AKT1—thyroid cancer	1.05e-05	8.39e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NRAS—thyroid cancer	1.05e-05	8.37e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NRAS—thyroid cancer	1.04e-05	8.36e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—KRAS—thyroid cancer	1.04e-05	8.34e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	1.04e-05	8.33e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—KRAS—thyroid cancer	1.04e-05	8.3e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PPARG—thyroid cancer	1.03e-05	8.22e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—HRAS—thyroid cancer	1.02e-05	8.14e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—KRAS—thyroid cancer	1.01e-05	8.07e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—AKT1—thyroid cancer	9.64e-06	7.72e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TP53—thyroid cancer	9.59e-06	7.68e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTGS2—thyroid cancer	9.53e-06	7.63e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	9.51e-06	7.62e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TP53—thyroid cancer	9.26e-06	7.41e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TP53—thyroid cancer	9.21e-06	7.38e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	9.17e-06	7.35e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—KRAS—thyroid cancer	9.15e-06	7.32e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—AKT1—thyroid cancer	9.05e-06	7.25e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—KRAS—thyroid cancer	9e-06	7.21e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—KRAS—thyroid cancer	8.98e-06	7.19e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—AKT1—thyroid cancer	8.97e-06	7.18e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TP53—thyroid cancer	8.96e-06	7.17e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—HRAS—thyroid cancer	8.85e-06	7.09e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—HRAS—thyroid cancer	8.81e-06	7.05e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—HRAS—thyroid cancer	8.57e-06	6.86e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTEN—thyroid cancer	8.31e-06	6.65e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	8.19e-06	6.56e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TP53—thyroid cancer	8.13e-06	6.51e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	8.1e-06	6.49e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTGS2—thyroid cancer	8.07e-06	6.46e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TP53—thyroid cancer	8e-06	6.41e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TP53—thyroid cancer	7.98e-06	6.39e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PPARG—thyroid cancer	7.92e-06	6.34e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—AKT1—thyroid cancer	7.82e-06	6.26e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—AKT1—thyroid cancer	7.78e-06	6.23e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HRAS—thyroid cancer	7.77e-06	6.23e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—HRAS—thyroid cancer	7.65e-06	6.13e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HRAS—thyroid cancer	7.63e-06	6.11e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—AKT1—thyroid cancer	7.56e-06	6.06e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—AKT1—thyroid cancer	7.35e-06	5.89e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TP53—thyroid cancer	7.28e-06	5.83e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTEN—thyroid cancer	7.04e-06	5.64e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	6.96e-06	5.57e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—AKT1—thyroid cancer	6.89e-06	5.52e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—AKT1—thyroid cancer	6.86e-06	5.5e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—AKT1—thyroid cancer	6.75e-06	5.41e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—AKT1—thyroid cancer	6.74e-06	5.4e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTGS2—thyroid cancer	6.23e-06	4.99e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	6.14e-06	4.92e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTEN—thyroid cancer	5.43e-06	4.35e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—AKT1—thyroid cancer	4.79e-06	3.84e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—AKT1—thyroid cancer	4.06e-06	3.25e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AKT1—thyroid cancer	3.13e-06	2.51e-05	CbGpPWpGaD
